Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS)
Status:
Active, not recruiting
Trial end date:
2031-04-01
Target enrollment:
Participant gender:
Summary
This research study is evaluating how well Breast Cancer responds to preoperative treatment
with Endocrine treatment in combination with a drug called Palbociclib or Endocrine treatment
alone as possible treatments for Hormone Receptor Positive Breast Cancer.